- Home
- LGO vs VIGL Comparison
LGO vs VIGL Comparison
Compare LGO & VIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGO
- VIGL
- Stock Information
- Founded
- LGO 1988
- VIGL 2020
- Country
- LGO Canada
- VIGL United States
- Employees
- LGO N/A
- VIGL N/A
- Industry
- LGO
- VIGL Biotechnology: Pharmaceutical Preparations
- Sector
- LGO
- VIGL Health Care
- Exchange
- LGO Nasdaq
- VIGL Nasdaq
- Market Cap
- LGO 134.0M
- VIGL 141.5M
- IPO Year
- LGO 2007
- VIGL 2022
- Fundamental
- Price
- LGO $2.05
- VIGL $3.00
- Analyst Decision
- LGO Strong Buy
- VIGL Buy
- Analyst Count
- LGO 1
- VIGL 5
- Target Price
- LGO $4.20
- VIGL $16.80
- AVG Volume (30 Days)
- LGO 231.0K
- VIGL 51.3K
- Earning Date
- LGO 11-12-2024
- VIGL 11-07-2024
- Dividend Yield
- LGO N/A
- VIGL N/A
- EPS Growth
- LGO N/A
- VIGL N/A
- EPS
- LGO N/A
- VIGL N/A
- Revenue
- LGO $144,822,000.00
- VIGL N/A
- Revenue This Year
- LGO N/A
- VIGL N/A
- Revenue Next Year
- LGO $30.88
- VIGL N/A
- P/E Ratio
- LGO N/A
- VIGL N/A
- Revenue Growth
- LGO N/A
- VIGL N/A
- 52 Week Low
- LGO $1.38
- VIGL $2.47
- 52 Week High
- LGO $2.84
- VIGL $6.06
- Technical
- Relative Strength Index (RSI)
- LGO 46.47
- VIGL 32.87
- Support Level
- LGO $1.87
- VIGL $2.89
- Resistance Level
- LGO $2.13
- VIGL $3.26
- Average True Range (ATR)
- LGO 0.17
- VIGL 0.22
- MACD
- LGO -0.05
- VIGL -0.08
- Stochastic Oscillator
- LGO 22.78
- VIGL 9.40
About LGO Largo Inc.
Largo Inc is committed to the production and supply of high-quality vanadium products. The Company is also focused on the advancement of renewable energy storage solutions through Largo Clean Energy and its vanadium redox flow battery technology. The Company is engaged in the mining, exploration, and development of mineral properties, predominantly in Brazil, through which it produces and supplies vanadium products VPURE Flake, VPURE+ Flake, and VPURE+ Powder. The Company has six operating segments: sales & trading wich generates key revenue, mine properties, corporate, exploration and evaluation properties, Largo Clean Energy, and Largo Physical Vanadium.
About VIGL Vigil Neuroscience Inc.
Vigil Neuroscience Inc is a microglia-focused therapeutics company treating both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain's immune system. It is utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and families. Its clinical candidate, iluzanebart, is currently being studied in IGNITE, a Phase 2 PoC trial and the first-ever interventional trial in ALSP patients. The company is also developing VG-3927, an orally available small molecule TREM2 agonist for the treatment of common neurodegenerative diseases associated with microglial dysfunction.